HLB Pharmaceutical Co., Ltd. (KOSDAQ: 047920)

Market Cap	377.74B
Revenue (ttm)	36.10B
Net Income (ttm)	472.66M
Shares Out	14.04M
EPS (ttm)	34.13
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	131,887
Open	26,850
Previous Close	26,650
Day's Range	26,350 - 27,100
52-Week Range	11,880 - 42,050
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About HLB Pharmaceutical

HLB Pharmaceutical Co., Ltd., a pharmaceutical company, researches and develops peptide drugs in South Korea. The company offers skeletal muscle relaxants, tranquilizers, antihistamines, antihypertensive agents, pain relief, antipruritics, astringents, anti-inflammatories, alimentary system drugs, metabolic drugs, ophthalmic agents, local anesthetics, antiarteriosclerotic agents, expectorants, antipyretics, analgesics, antidiabetic drug, chemotherapeutics, peptic ulcer agents, central nervous system drug, antibiotics, digestives, antacids, dent...

• Industry: Pharmaceutical Preparations
• Founded: 1998
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 047920